发明名称 |
THERAPY FOR LEUKEMIA |
摘要 |
A pharmaceutically acceptable composition and method for leukemia therapy in a patient in need of such therapy. The composition contains, as the only active agents, the combination of (a) an inhibitor of c-Fos, (b) an inhibitor of Dusp-1, and (c) an inhibitor of BCR-ABL tyrosine kinase. The composition is administered to the patient in a dosing regimen for a period sufficient to provide therapy for leukemia. |
申请公布号 |
WO2012145575(A3) |
申请公布日期 |
2013.02.07 |
申请号 |
WO2012US34359 |
申请日期 |
2012.04.20 |
申请人 |
CHILDREN'S HOSPITAL MEDICAL CENTER;AZAM, MOHAMMAD;KESARWANI, MEENU |
发明人 |
AZAM, MOHAMMAD;KESARWANI, MEENU |
分类号 |
A61K31/12;A61K31/506;A61K31/517;A61P35/00;A61P35/02 |
主分类号 |
A61K31/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|